Geode Capital Management LLC Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Geode Capital Management LLC boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,906,463 shares of the medical device company’s stock after acquiring an additional 109,907 shares during the period. Geode Capital Management LLC’s holdings in Cooper Companies were worth $449,907,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Fulton Bank N.A. grew its stake in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Torray Investment Partners LLC boosted its holdings in Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. boosted its holdings in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its stake in Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares in the last quarter. Finally, Greenleaf Trust increased its holdings in Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 5.6 %

Shares of NASDAQ COO opened at $73.77 on Friday. The Cooper Companies, Inc. has a 12-month low of $73.34 and a 12-month high of $112.38. The company has a market cap of $14.75 billion, a price-to-earnings ratio of 37.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock’s 50 day simple moving average is $87.76 and its 200 day simple moving average is $96.33.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on COO. Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research report on Friday, March 7th. Citigroup decreased their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a report on Friday, March 7th. Stifel Nicolaus dropped their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Morgan Stanley lowered their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.